NCT07668310

Brief Summary

Carpal tunnel syndrome is a common condition caused by compression of the median nerve. Tingling in the first three or four fingers, usually at night or upon waking, is the most frequent symptom. Reduced sensation in the fingers and clumsiness can also occur, and in severe cases, there may even be weakness in thumb abduction with thenar muscle wasting. Carpal tunnel syndrome (CTS) is the most commonly diagnosed nerve compression syndrome. The annual incidence of diagnosis varies depending on the study and the country. It's estimated at 3.8 per thousand in the general population, 1 to 2 per thousand in men, 4 to 5 per thousand in women, with a peak between ages 40 and 60. Medical treatment combines removing a microtraumatic factor, immobilization with a brace, and giving 1 to 2 cortisone injections into the carpal tunnel. The results are good in purely sensory cases. If it doesn't work, things get worse despite treatment, or in severe cases from the start (severe sensory problems, loss of strength, muscle wasting), surgery is recommended. Several teams have recently demonstrated the benefits of using a minimally invasive ultrasound-guided surgical technique to perform flexor retinaculum sectioning under ultrasound guidance. This technique offers increased safety thanks to continuous ultrasound monitoring and the visualization of median nerve variants. Rojo et al. compared ultrasound surgery with a 1 mm incision to mini-open surgery with a 20 mm incision in 128 patients. This study suggests that a minimally invasive approach could allow for faster functional pain recovery compared to conventional surgery. This project is based on the hypothesis that the proposed ultrasound-guided percutaneous release technique has an efficacy and tolerability profile suitable for widespread use in the indication of carpal tunnel syndrome resistant to conservative treatment, and that it can therefore reduce the need for conventional surgery in this indication.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 19, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 25, 2026

Completed
Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

2.2 years

First QC Date

June 19, 2026

Last Update Submit

July 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Severity of symptoms" subscore of the Boston Questionnaire

    The "Severity of symptoms" subscore of the Boston Questionnaire, specific to carpal tunnel syndrome, 3 months post-intervention, assessed by the clinical research associate, blinded to the procedure performed. Eleven questions with a score between 1 and 5 for each items. The final score is between 11 (no symptoms) and 55 (very high severity).

    3 months after surgery

Study Arms (2)

Patient undergoing percutaneous ultrasound-guided carpal tunnel release procedure.

EXPERIMENTAL
Procedure: Carpal tunnel surgeryOther: Questionnaires

Patient undergoing conventional surgery.

ACTIVE COMPARATOR
Procedure: Carpal tunnel surgeryOther: Questionnaires

Interventions

The aim of this study is to compare the conventional surgery to the percutaneous ultrasound-guided carpal tunnel release procedure. One group is doing the conventional surgery and the other the procédure to evaluate.

Patient undergoing conventional surgery.Patient undergoing percutaneous ultrasound-guided carpal tunnel release procedure.

EVA, Boston and Quick Dash questionnaires : all study visits

Patient undergoing conventional surgery.Patient undergoing percutaneous ultrasound-guided carpal tunnel release procedure.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient, male or female, over 18 years of age
  • Patient with clinical carpal tunnel syndrome
  • Patient with unilateral or bilateral carpal tunnel syndrome. In the case of bilateral involvement, the more symptomatic hand (with the highest Boston score) will be included, with the patient agreeing that the second hand will not be operated on within one year.
  • Patient with carpal tunnel syndrome confirmed by an EMG less than 6 months old
  • Patient with carpal tunnel syndrome without motor or sensory deficits
  • Patient with carpal tunnel syndrome resistant to conservative treatment, including at least one corticosteroid injection
  • Patient agreeing to undergo surgery
  • Patient affiliated with or covered by a social security plan
  • Patient who has been informed and has signed a free and informed written consent.

You may not qualify if:

  • Patient with another condition of the hand or wrist (Dupuytren's disease, inflammatory rheumatism, symptomatic osteoarthritis)
  • Patient with a history of previous hand or wrist surgery requiring treatment
  • Neurological sequelae of the hand
  • Patient with non-medicinal hypocoagulation or vitamin K antagonist overdose
  • Patient with a known allergy to lidocaine
  • Patient with an unhealed palmo-digital wound
  • Patient with a superficial or deep palmo-digital infection or inflammation
  • Patient who has received a cortisone injection in the hand or wrist within the last month. - Patient with type 1 diabetes or poorly controlled diabetes (HbA1c \>7.5% for less than 3 months)
  • Patient with cognitive impairment deemed incompatible with the research by the investigator
  • Patient with a language barrier preventing a reliable assessment
  • Patient participating in another clinical trial
  • Protected patient: adult under guardianship, curatorship, or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant, breastfeeding, or postpartum woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Lariboisière

Paris, 75010, France

Location

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2026

First Posted

June 25, 2026

Study Start

January 1, 2023

Primary Completion

March 15, 2025

Study Completion

March 15, 2025

Last Updated

July 16, 2026

Record last verified: 2026-07

Locations